Ian F. Smith
2013
In 2013, Ian F. Smith earned a total compensation of $4.2M as EVP & Chief Financial Officer at Vertex Pharmaceuticals, a 35% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $682,500 |
|---|---|
| Option Awards | $2,361,640 |
| Salary | $582,959 |
| Stock Awards | $544,988 |
| Other | $12,675 |
| Total | $4,184,762 |
Smith received $2.4M in option awards, accounting for 56% of the total pay in 2013.
Smith also received $682.5K in non-equity incentive plan, $583K in salary, $545K in stock awards and $12.7K in other compensation.
Rankings
In 2013, Ian F. Smith's compensation ranked 1,639th out of 12,286 executives tracked by ExecPay. In other words, Smith earned more than 86.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,639 out of 12,286 | 87th |
Division Manufacturing | 540 out of 4,612 | 88th |
Major group Chemicals And Allied Products | 145 out of 1,462 | 90th |
Industry group Drugs | 97 out of 1,156 | 92nd |
Industry Pharmaceutical Preparations | 85 out of 890 | 90th |
Source: SEC filing on April 29, 2016.
Smith's colleagues
We found four more compensation records of executives who worked with Ian F. Smith at Vertex Pharmaceuticals in 2013.